Skip to Content

APR 20 (Otezla 20 mg)

Generic Name: apremilast

Pill with imprint APR 20 is Brown, Four-sided and has been identified as Otezla 20 mg. It is supplied by Celgene Corporation.

Otezla is used in the treatment of plaque psoriasis; behcet's disease; psoriatic arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Otezla 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APR 20

Otezla 20 mg APR 20

Otezla

Generic Name
apremilast
Imprint
APR 20
Strength
20 mg
Color
Brown
Shape
Four-sided
Availability
Prescription only
Drug Class
Antirheumatics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Celgene Corporation

Labelers / Repackagers

NDC CodeLabeler / Repackager
59572-0630 Celgene Corporation
59572-0632 Celgene Corporation

Get help with Imprint Code FAQs.

Related Images for "APR 20"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.